[Future of immunologic therapy of bronchogenic carcinoma].
The AA. report their experience as to the treatment applied to patients suffering from unremovable bronchial cancers. They can therefore stress the results obtained by chemotherapeutic treatment associated to thymopentin as well as interferon-thymopentin treatment. Elderly patients were subjected to interferon-thymopentin therapy, which helped in improving their life standard and survival.
Saviano
G
G
VIII Divisione di Pneumotisiologia, U.S.L. 41, Ospedale V. Monaldi, Napoli.
Borrelli
G
G
Cerbone
V
V
La Gala
F
F
Ferrara
P
P
D000328:Adult; D000368:Aged; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D018288:Carcinoma, Small Cell / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D007372:Interferons / Q000008:administration & dosage / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000188:drug therapy*; D008875:Middle Aged; D016305:Thymopentin / Q000008:administration & dosage / Q000627:therapeutic use*
D007372:Interferons; D016305:Thymopentin
Un futuro alla terapia immunologica del ca broncogeno.